speb/financial-data huggingface dataset:
Financial ratios for 1823.HK — annual report dated 2022-12-31
Total revenue: 52616944.801026955
Gross profit: 15363928.11296534
Operating income: 8362772.785622593
Net income: 11157124.518613607
Capital expenditures: 504621.30937098846
Operating cash flow: 25506803.59435173
Depreciation & amortization: 8224133.504492939
Net tangible assets: 51742875.48138639
Owner earnings: 18876636.713735558
Return on net tangible assets (%): 36.481615175264274
Capex to operating income (%): 6.034138703834464
Buffett classification: The Great
Stock price: 0.17586649550706035
P/E ratio: 7.425937823595739
Shares outstanding: 471108000
Book value: 103084724.00513479
P/B ratio: 0.8037283289540864
Market cap (USD): 82852112.96534018
Debt to equity: 0.06431889219580837
Current ratio: 1.4804916284868292
Quick ratio: 1.3417402718410216
Effective tax rate (%): 28.17244802616211
Interest coverage ratio: 42.49575994781475
COGS to revenue (%): 70.80041767711023
SG&A to revenue (%): 13.305894809776378
Free cash flow (dilution-adjusted): 21699486.521181002
Buyback yield (%): 0
Retained earnings: -29481899.871630296
Inventory turnover: 1.8145160786079169
Receivables turnover: 407.03674280039723
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.109867756845881
FCF margin (%): 41.24049125854506
Revenue growth (%): -40.38623325257095
Rule of 40 score: 0.8542580059741098
Financial ratios for 1823.HK — annual report dated 2023-12-31
Total revenue: 52125992.317541614
Gross profit: 14726504.48143406
Operating income: 5215620.998719591
Net income: 46009987.19590269
Capital expenditures: 6361587.708066582
Operating cash flow: 8139052.496798976
Depreciation & amortization: 4990012.804097312
Net tangible assets: 70106914.21254802
Owner earnings: 44638412.29193342
Return on net tangible assets (%): 63.67191138466034
Capex to operating income (%): 121.97181715520205
Buffett classification: The Gruesome
Stock price: 0.12163892445582586
P/E ratio: 1.2454919880446822
Shares outstanding: 471108000
Book value: 143920870.67861718
P/B ratio: 0.39817067637466164
Market cap (USD): 57305070.42253521
Debt to equity: 0.0012980172985937997
Current ratio: 5.776370258648353
Quick ratio: 3.7175486169052046
Effective tax rate (%): 56.67144172720761
Interest coverage ratio: 21.853004291845494
COGS to revenue (%): 71.74825106115391
SG&A to revenue (%): 18.24595189435623
Free cash flow (dilution-adjusted): 1777464.7887323943
Buyback yield (%): 20.35313837971224
Retained earnings: 4595262.483994879
Inventory turnover: 1.1381844537618655
Receivables turnover: 176.77116804168475
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6221458284055763
FCF margin (%): 3.4099394749253262
Revenue growth (%): -0.9330691573634639
Rule of 40 score: 2.4768703175618625
Financial ratios for 1823.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 67626804.12371135
Buffett classification: The Gruesome
Stock price: 0.06829896907216496
Shares outstanding: 471108000
Book value: 138972809.2783505
P/B ratio: 0.23152867736309027
Market cap (USD): 32176190.721649487
Debt to equity: 0.22951997767122365
Current ratio: 3.044937300263258
Quick ratio: 1.3783147232379436
Buyback yield (%): 0
Retained earnings: -2347164.9484536084
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1823.HK — annual report dated 2024-12-31
Total revenue: 25534149.48453608
Gross profit: 5090721.649484537
Operating income: -2344458.762886598
Net income: -1097164.9484536082
Capital expenditures: 22881056.70103093
Operating cash flow: -32283247.42268041
Depreciation & amortization: 5140206.18556701
Net tangible assets: 67626804.12371135
Owner earnings: -18838015.463917527
Return on net tangible assets (%): -27.85584164151346
Buffett classification: The Gruesome
Stock price: 0.06829896907216496
Shares outstanding: 471108000
Book value: 138972809.2783505
P/B ratio: 0.23152867736309027
Market cap (USD): 32176190.721649487
Debt to equity: 0.22951997767122365
Current ratio: 3.044937300263258
Quick ratio: 1.3783147232379436
Interest coverage ratio: -3.5658565268522144
COGS to revenue (%): 80.0630851144364
SG&A to revenue (%): 29.11857478109465
Free cash flow (dilution-adjusted): -55164304.12371134
Buyback yield (%): 0
Retained earnings: -2347164.9484536084
Inventory turnover: 0.40613863515340193
Receivables turnover: 40.939049586776854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.543823264355019
FCF margin (%): -216.04128289888718
Revenue growth (%): -51.014554641018805
Rule of 40 score: -267.05583753990595
Financial ratios for 1925.T — annual report dated 2022-03-31
Total revenue: 36383674807.40862
Gross profit: 7086395672.840518
Operating income: 3140976889.0345845
Net income: 1876397311.9160793
Capital expenditures: 120250778.56089166
Operating cash flow: 2757220127.8478937
Depreciation & amortization: 822225864.6123587
Net tangible assets: 15155220455.663006
Owner earnings: 2578372397.9675465
Return on net tangible assets (%): 17.013097272392987
Capex to operating income (%): 3.8284515553329053
Buffett classification: The Great
Stock price: 22.798803474840188
P/E ratio: 7.525257370572113
Shares outstanding: 619347095
Book value: 17303589575.479435
P/B ratio: 0.8160371950585252
Market cap (USD): 14120372701.618176
Debt to equity: 0.7265599246749996
Current ratio: 1.864051579961678
Quick ratio: 0.7824956804412596
Effective tax rate (%): 35.19416926125106
Interest coverage ratio: 29.407043658405584
COGS to revenue (%): 80.52312223619765
SG&A to revenue (%): 2.066342068180098
Free cash flow (dilution-adjusted): -610924438.6166203
Buyback yield (%): 0.0006964726481457011
Retained earnings: 12185707261.104738
Inventory turnover: 2.288042104266046
Receivables turnover: 10.896438652038386
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.400427267621108
FCF margin (%): -1.6791169167228288
Rule of 40 score: -1.6791169167228288
Financial ratios for 1925.T — annual report dated 2023-03-31
Total revenue: 36848340840.84084
Gross profit: 7171126126.126126
Operating income: 3493798798.798799
Net income: 2369947447.447448
Capital expenditures: 59264264.26426427
Operating cash flow: 1728963963.9639642
Depreciation & amortization: 851831831.8318319
Net tangible assets: 15695315315.315317
Owner earnings: 3162515015.0150156
Return on net tangible assets (%): 20.14942007523142
Capex to operating income (%): 1.6962700967393967
Buffett classification: The Great
Stock price: 21.211111111111116
P/E ratio: 5.543177787565772
Shares outstanding: 619347095
Book value: 17934767267.267273
P/B ratio: 0.7324901323010359
Market cap (USD): 13137040048.388891
Debt to equity: 0.8171392739202086
Current ratio: 2.1298715588398833
Quick ratio: 0.7599412383821037
Effective tax rate (%): 28.336012131778727
Interest coverage ratio: 24.70662561053302
COGS to revenue (%): 80.53878826021521
SG&A to revenue (%): 2.035145681745993
Free cash flow (dilution-adjusted): -1923558558.5585587
Buyback yield (%): 0.00057147633560181
Retained earnings: 12842207207.207209
Inventory turnover: 1.8898757645789928
Receivables turnover: 10.802896943044981
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.083462976846173
FCF margin (%): -5.220203989284053
Revenue growth (%): 1.2771278214525017
Rule of 40 score: -3.943076167831551
Financial ratios for 1925.T — annual report dated 2024-03-31
Total revenue: 34356306127.83941
Gross profit: 6553136555.731643
Operating income: 2906874009.5087166
Net income: 1982653195.9852087
Capital expenditures: 83663497.09455891
Operating cash flow: 1996130480.7184365
Depreciation & amortization: 773930269.4136292
Net tangible assets: 14753697834.125727
Owner earnings: 2672919968.3042793
Return on net tangible assets (%): 18.116949380119056
Capex to operating income (%): 2.878126015124359
Buffett classification: The Great
Stock price: 27.990161119915477
P/E ratio: 8.743649677767916
Shares outstanding: 619347095
Book value: 16665088483.888008
P/B ratio: 1.0402359996445185
Market cap (USD): 17335624978.2016
Debt to equity: 0.8733703389504791
Current ratio: 2.3834928823298944
Quick ratio: 0.8895912237168604
Effective tax rate (%): 34.13106525621169
Interest coverage ratio: 13.961403063651645
COGS to revenue (%): 80.92593792061726
SG&A to revenue (%): 1.9951300414248232
Free cash flow (dilution-adjusted): -354952456.41838354
Buyback yield (%): 3.3204116108861155
Retained earnings: 12568185419.968304
Inventory turnover: 1.8404505540570018
Receivables turnover: 10.549201650429335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.800254921665363
FCF margin (%): -1.03315081399499
Revenue growth (%): -6.762949582357828
Rule of 40 score: -7.796100396352818
Financial ratios for 1925.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 16514014567.866648
Buffett classification: The Gruesome
Stock price: 30.031587057010785
Shares outstanding: 619347095
Book value: 18773735817.341366
P/B ratio: 0.9907445371005149
Market cap (USD): 18599976201.99923
Debt to equity: 0.8673034350874496
Current ratio: 2.3522412529728625
Quick ratio: 0.895711043493652
Buyback yield (%): 0
Retained earnings: 14066977167.670542
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1925.T — annual report dated 2025-03-31
Total revenue: 36324147841.1977
Gross profit: 7359076326.694292
Operating income: 3651156262.531747
Net income: 2204765405.6944256
Capital expenditures: 64790803.36853362
Operating cash flow: 2810860847.4802833
Depreciation & amortization: 880804705.2533083
Net tangible assets: 16101858040.368935
Owner earnings: 3020779307.5792003
Return on net tangible assets (%): 18.760439323249596
Capex to operating income (%): 1.7745283606023219
Buffett classification: The Great
Stock price: 31.908702045181126
P/E ratio: 8.963566765816049
Shares outstanding: 619347095
Book value: 18157619302.232323
P/B ratio: 1.08838948476433
Market cap (USD): 19762561916.90349
Debt to equity: 0.8954943474594395
Current ratio: 2.1171294675526795
Quick ratio: 0.7148024303181204
Effective tax rate (%): 32.51033689796903
Interest coverage ratio: 13.143565190193202
COGS to revenue (%): 79.74053965734646
SG&A to revenue (%): 1.9746931774544836
Free cash flow (dilution-adjusted): 259156529.87568507
Buyback yield (%): 3.382456696292518
Retained earnings: 14254885710.466515
Inventory turnover: 1.6852134925835118
Receivables turnover: 11.446784894374355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.474300683981886
FCF margin (%): 0.7134552227038288
Revenue growth (%): 5.7277453112566175
Rule of 40 score: 6.441200533960446
Financial ratios for 1925.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 16101858040.368935
Buffett classification: The Gruesome
Stock price: 31.908702045181126
Shares outstanding: 619347095
Book value: 18157619302.232323
P/B ratio: 1.08838948476433
Market cap (USD): 19762561916.90349
Debt to equity: 0.8954943474594395
Current ratio: 2.1171294675526795
Quick ratio: 0.7148024303181204
Buyback yield (%): 0
Retained earnings: 14254885710.466515
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1925.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.14177968447273
Shares outstanding: 619347095
Market cap (USD): 20526264970.708202
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1925.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 16531130551.81696
Buffett classification: The Gruesome
Stock price: 35.09044414535666
Shares outstanding: 619347095
Book value: 18458465679.67699
P/B ratio: 1.1774090555974488
Market cap (USD): 21733164643.68641
Debt to equity: 0.9757255750059788
Current ratio: 1.995406539703398
Quick ratio: 0.6372993641469052
Buyback yield (%): 0
Retained earnings: 14946534320.323015
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2455.HK — annual report dated 2023-12-31
Total revenue: 108074261.60337552
Gross profit: 18736286.919831224
Operating income: 7848945.147679324
Net income: 5869057.665260197
Capital expenditures: 678621.6596343179
Operating cash flow: 7526441.631504922
Depreciation & amortization: 3584106.891701828
Net tangible assets: 47551195.49929676
Owner earnings: 8774542.897327706
Return on net tangible assets (%): 18.45283342551813
Capex to operating income (%): 8.646023725047487
Buffett classification: The Great
Stock price: 0.07170294494238157
P/E ratio: 3.5970932720922995
Shares outstanding: 294430694
Book value: 47957383.96624472
P/B ratio: 0.4402147509982773
Market cap (USD): 21111547.841229193
Debt to equity: 0.49880197198051485
Current ratio: 1.5942834804522117
Quick ratio: 1.5938960499541017
Effective tax rate (%): 23.43021762266505
Interest coverage ratio: 5.739586547361925
COGS to revenue (%): 82.66350688696629
SG&A to revenue (%): 10.441848601263914
Free cash flow (dilution-adjusted): 6434177.215189873
Buyback yield (%): 0
Retained earnings: 25256258.790436003
Inventory turnover: 5722.459459459459
Receivables turnover: 3.969562185199535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.006996918745308
FCF margin (%): 5.9534778398975545
Revenue growth (%): 8.699125397506881
Rule of 40 score: 14.652603237404435
Financial ratios for 2455.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 48124383.56164384
Buffett classification: The Gruesome
Stock price: 0.06958762886597938
Shares outstanding: 294430694
Book value: 48402328.76712329
P/B ratio: 0.42330058042045027
Market cap (USD): 20488733.86082474
Debt to equity: 0.4528679419364516
Current ratio: 1.6677386617661176
Quick ratio: 1.667272378183414
Buyback yield (%): 0
Retained earnings: 25874109.589041095
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2455.HK — annual report dated 2024-12-31
Total revenue: 123793287.67123288
Gross profit: 17518630.1369863
Operating income: 8043561.643835616
Net income: 6240821.91780822
Capital expenditures: 969863.0136986302
Operating cash flow: 4944794.520547945
Depreciation & amortization: 3438493.150684932
Net tangible assets: 48124383.56164384
Owner earnings: 8709452.054794522
Return on net tangible assets (%): 18.097794527878673
Capex to operating income (%): 12.057631390714944
Buffett classification: The Great
Stock price: 0.06958762886597938
P/E ratio: 3.2830185079244174
Shares outstanding: 294430694
Book value: 48402328.76712329
P/B ratio: 0.42330058042045027
Market cap (USD): 20488733.86082474
Debt to equity: 0.4528679419364516
Current ratio: 1.6677386617661176
Quick ratio: 1.667272378183414
Effective tax rate (%): 22.07538437805317
Interest coverage ratio: 7.024524464648881
COGS to revenue (%): 85.848481394636
SG&A to revenue (%): 8.313793099632507
Free cash flow (dilution-adjusted): 3419589.0410958906
Buyback yield (%): 0
Retained earnings: 25874109.589041095
Inventory turnover: 5704.448529411764
Receivables turnover: 3.500426082443079
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.243297494919695
FCF margin (%): 2.7623380115548346
Revenue growth (%): 14.544652755107416
Rule of 40 score: 17.30699076666225
Financial ratios for 2814.T — annual report dated 2022-03-31
Total revenue: 46251811.17849533
Gross profit: 13415513.850188494
Operating income: 6413456.810358957
Net income: 5965718.734633666
Capital expenditures: 1613120.799868874
Operating cash flow: 6920111.457138174
Depreciation & amortization: 2220070.4802491395
Net tangible assets: 153255482.70775282
Owner earnings: 6572668.415013932
Return on net tangible assets (%): 4.288700344605314
Capex to operating income (%): 25.152126966277777
Buffett classification: The Good
Stock price: 11.156613669890183
P/E ratio: 6.709770270957514
Shares outstanding: 3587881
Book value: 153583527.2906081
P/B ratio: 0.2606308301201979
Market cap (USD): 40028602.21053926
Debt to equity: 0.03575190144086566
Current ratio: 7.890397264226982
Quick ratio: 6.946167496442633
Effective tax rate (%): 17.17105974318566
Interest coverage ratio: 213.17624625442656
COGS to revenue (%): 70.99460171669165
R&D to revenue (%): 3.915943700224996
SG&A to revenue (%): 3.0771596942827384
Free cash flow (dilution-adjusted): 5306990.6572693
Buyback yield (%): 0.0035624420031036843
Retained earnings: 29591304.704146862
Inventory turnover: 2.8149378409613837
Receivables turnover: 4.552325994089026
Capitalized R&D asset: 1811194.8860842485
ROCI (R&D-adjusted, %): 4.886135161446661
FCF margin (%): 11.474125060289039
Rule of 40 score: 11.474125060289039
Financial ratios for 2814.T — annual report dated 2023-03-31
Total revenue: 44156951.95195196
Gross profit: 11384474.474474475
Operating income: 4640735.735735736
Net income: 2888423.423423424
Capital expenditures: 2615773.2732732734
Operating cash flow: 4153776.2762762764
Depreciation & amortization: 2181171.171171171
Net tangible assets: 142729527.02702704
Owner earnings: 2453821.3213213217
Return on net tangible assets (%): 1.719210714442198
Capex to operating income (%): 56.365486470833744
Buffett classification: The Good
Stock price: 12.04391891891892
P/E ratio: 14.960461649876018
Shares outstanding: 3587881
Book value: 142952777.7777778
P/B ratio: 0.3022826735266638
Market cap (USD): 43212147.854729734
Debt to equity: 0.03518665469970291
Current ratio: 8.526828936051816
Quick ratio: 7.445834568117711
Effective tax rate (%): 0.7895802228462536
Interest coverage ratio: 168.0657966286025
COGS to revenue (%): 74.21814351142338
R&D to revenue (%): 4.2223293717843084
SG&A to revenue (%): 3.2099190268945783
Free cash flow (dilution-adjusted): 1538003.003003003
Buyback yield (%): 4.46710109578376
Retained earnings: 26646561.561561562
Inventory turnover: 2.925964330431472
Receivables turnover: 4.87111117736551
Capitalized R&D asset: 3077952.525628399
ROCI (R&D-adjusted, %): 3.602650256232408
Rosenberg metric: -1.1213809134063248
FCF margin (%): 3.4830370644163446
Revenue growth (%): -4.529247986546685
Rule of 40 score: -1.0462109221303404
Financial ratios for 2814.T — annual report dated 2024-03-31
Total revenue: 40288913.10089804
Gross profit: 10192881.669307977
Operating income: 4383650.29054411
Net income: 5105758.0559957735
Capital expenditures: 554331.7485472795
Operating cash flow: 7695212.625462229
Depreciation & amortization: 1848685.9482303222
Net tangible assets: 130229358.16164818
Owner earnings: 6400112.255678817
Return on net tangible assets (%): 4.914492665881551
Capex to operating income (%): 12.64543729099509
Buffett classification: The Great
Stock price: 12.893291072371897
P/E ratio: 9.06027930792948
Shares outstanding: 3587881
Book value: 130372754.88642368
P/B ratio: 0.3548256236997718
Market cap (USD): 46259594.06603275
Debt to equity: 0.03393496136732569
Current ratio: 6.973687985951106
Quick ratio: 6.182424211044089
Effective tax rate (%): 18.3895246910909
Interest coverage ratio: 176.46464646464648
COGS to revenue (%): 74.70052953828439
R&D to revenue (%): 3.0529130178175232
SG&A to revenue (%): 3.312855361753369
Free cash flow (dilution-adjusted): 7123276.545166403
Buyback yield (%): 4.129167291747139
Retained earnings: 25512209.455890123
Inventory turnover: 3.1066786451172703
Receivables turnover: 3.9365497921188393
Capitalized R&D asset: 3076862.5930101164
ROCI (R&D-adjusted, %): 2.9449814992098675
Rosenberg metric: -0.6391115651540297
FCF margin (%): 17.680488245803843
Revenue growth (%): -8.759750571694362
Rule of 40 score: 8.920737674109482
Financial ratios for 2814.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 135074331.13881496
Buffett classification: The Gruesome
Stock price: 13.916234766774059
Shares outstanding: 3587881
Book value: 135188548.81636083
P/B ratio: 0.36933449429265164
Market cap (USD): 49929794.31124808
Debt to equity: 0.03471103144037155
Current ratio: 7.751881163391064
Quick ratio: 6.810774621418186
Buyback yield (%): 0
Retained earnings: 100226047.06541532
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2814.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 128875464.51009223
Buffett classification: The Gruesome
Stock price: 15.343871140221895
Shares outstanding: 3587881
Book value: 128955300.09357038
P/B ratio: 0.42690749190226823
Market cap (USD): 55051983.730450474
Debt to equity: 0.034725295957996276
Current ratio: 8.211753197844082
Quick ratio: 7.160602691308189
Buyback yield (%): 0
Retained earnings: 26654036.89346344
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2814.T — annual report dated 2025-03-31
Total revenue: 42512271.08675311
Gross profit: 10915258.655259991
Operating income: 4498001.604063627
Net income: 3986311.990375618
Capital expenditures: 1729381.098783585
Operating cash flow: 6162090.629594973
Depreciation & amortization: 1821427.6166287928
Net tangible assets: 128875464.51009223
Owner earnings: 4078358.5082208253
Return on net tangible assets (%): 3.164573275234596
Capex to operating income (%): 38.447765274721355
Buffett classification: The Good
Stock price: 15.343871140221895
P/E ratio: 13.810254657278618
Shares outstanding: 3587881
Book value: 128955300.09357038
P/B ratio: 0.42690749190226823
Market cap (USD): 55051983.730450474
Debt to equity: 0.034725295957996276
Current ratio: 8.211753197844082
Quick ratio: 7.160602691308189
Effective tax rate (%): 32.014426211569244
Interest coverage ratio: 114.64923339011924
COGS to revenue (%): 74.32443607497682
R&D to revenue (%): 2.8257958339713674
SG&A to revenue (%): 3.118956037131844
Free cash flow (dilution-adjusted): 4431051.998395937
Buyback yield (%): 5.175844659275981
Retained earnings: 26654036.89346344
Inventory turnover: 2.9329161010787326
Receivables turnover: 5.381222742520188
Capitalized R&D asset: 2640669.3962125466
ROCI (R&D-adjusted, %): 3.1884143780519043
Rosenberg metric: 0.587305299070554
FCF margin (%): 10.422995255543192
Revenue growth (%): 5.51853553429692
Rule of 40 score: 15.941530789840112
Financial ratios for 2814.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.817187932466094
Shares outstanding: 3587881
Market cap (USD): 56750188.056324385
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2814.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 130700080.75370121
Buffett classification: The Gruesome
Stock price: 21.88479138627187
Shares outstanding: 3587881
Book value: 130806931.35935399
P/B ratio: 0.6002742086201655
Market cap (USD): 78520027.2037685
Debt to equity: 0.03446872631882748
Current ratio: 6.422785028280456
Quick ratio: 5.51556658138405
Buyback yield (%): 0
Retained earnings: 96968122.47644684
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2HRA.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.511363636363637
Shares outstanding: 37221746
Market cap (USD): 279586069.3863636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2HRA.DE — annual report dated 2022-12-31
Total revenue: 1676641489.3617022
Gross profit: 360363829.78723407
Operating income: 76253191.4893617
Net income: 48259574.46808511
Capital expenditures: 68811702.12765957
Operating cash flow: 40404255.319148935
Depreciation & amortization: 58853191.4893617
Net tangible assets: 414173404.2553192
Owner earnings: 38301063.82978724
Return on net tangible assets (%): 9.247591331619248
Capex to operating income (%): 90.24107815508245
Buffett classification: The Gruesome
Stock price: 6.031914893617022
P/E ratio: 4.652307993563178
Shares outstanding: 37221746
Book value: 501238297.8723405
P/B ratio: 0.44792747285446255
Market cap (USD): 224518404.0638298
Debt to equity: 0.5183778896520107
Current ratio: 1.5423531692188408
Quick ratio: 0.7620305852827455
Effective tax rate (%): 26.866465685405217
Interest coverage ratio: 10.162767616617042
COGS to revenue (%): 78.50680470012557
SG&A to revenue (%): 3.449588621630247
Free cash flow (dilution-adjusted): -34084042.55319149
Buyback yield (%): 0
Retained earnings: 290201063.82978725
Inventory turnover: 5.392135585538472
Receivables turnover: 12.666406808811592
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.730094953810502
FCF margin (%): -2.0328760065556586
Rule of 40 score: -2.0328760065556586
Financial ratios for 2HRA.DE — annual report dated 2023-12-31
Total revenue: 1502505555.5555556
Gross profit: 336536666.6666667
Operating income: 39245555.55555555
Net income: 11736666.666666666
Capital expenditures: 58387777.777777776
Operating cash flow: 132298888.88888888
Depreciation & amortization: 64958888.88888889
Net tangible assets: 417220000
Owner earnings: 18307777.777777776
Return on net tangible assets (%): 4.388039350409323
Capex to operating income (%): 148.77551598199372
Buffett classification: The Gruesome
Stock price: 4.988888888888889
P/E ratio: 15.82179679447127
Shares outstanding: 37221746
Book value: 502945555.5555556
P/B ratio: 0.36921522219104785
Market cap (USD): 185695155.04444444
Debt to equity: 0.3480871576556773
Current ratio: 1.6954119425233276
Quick ratio: 0.8360640720831753
Effective tax rate (%): 43.828768944429676
Interest coverage ratio: 2.882170542635659
COGS to revenue (%): 77.60163578614979
SG&A to revenue (%): 3.539347238501614
Free cash flow (dilution-adjusted): 68240000
Buyback yield (%): 0
Retained earnings: 304281111.1111111
Inventory turnover: 5.084486910512775
Receivables turnover: 12.780634185529985
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.306210133192319
FCF margin (%): 4.541746933825351
Revenue growth (%): -10.38599694156681
Rule of 40 score: -5.84425000774146
Financial ratios for 2HRA.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.122222222222222
Shares outstanding: 37221746
Market cap (USD): 153436308.51111108
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2HRA.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.4583333333333335
Shares outstanding: 37221746
Market cap (USD): 128725204.91666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2HRA.DE — annual report dated 2024-12-31
Total revenue: 1394000000
Gross profit: 330127083.3333334
Operating income: 38255208.333333336
Net income: 13172916.666666668
Capital expenditures: 53618750
Operating cash flow: 73170833.33333334
Depreciation & amortization: 61984375
Net tangible assets: 408022916.6666667
Owner earnings: 21538541.66666667
Return on net tangible assets (%): 5.278757831208419
Capex to operating income (%): 140.16065350578623
Buffett classification: The Gruesome
Stock price: 3.4583333333333335
P/E ratio: 9.771959253518899
Shares outstanding: 37221746
Book value: 482705208.3333334
P/B ratio: 0.2666745721702989
Market cap (USD): 128725204.91666667
Debt to equity: 0.4199422956989363
Current ratio: 1.5270847808035788
Quick ratio: 0.8124315805527782
Effective tax rate (%): 37.826941986234026
Interest coverage ratio: 3.1101795392953933
COGS to revenue (%): 76.31799976087996
SG&A to revenue (%): 3.6698200621712105
Free cash flow (dilution-adjusted): 15864583.333333334
Buyback yield (%): 0
Retained earnings: 290192708.3333334
Inventory turnover: 4.843537479488955
Receivables turnover: 9.912962318239394
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.082257144913176
FCF margin (%): 1.1380619320899092
Revenue growth (%): -7.221640888737703
Rule of 40 score: -6.083578956647793
Financial ratios for 2HRA.DE — quarterly report dated 2025-03-31
Total revenue: 375916304.34782606
Gross profit: 84797826.08695652
Operating income: 8463043.47826087
Net income: 2654347.8260869565
Capital expenditures: 9326086.956521738
Operating cash flow: -8771739.130434781
Depreciation & amortization: 15900000
Net tangible assets: 429068478.26086956
Owner earnings: 9228260.869565219
Return on net tangible assets (%): 2.1507664480434108
Capex to operating income (%): 110.19779090675573
Buffett classification: The Gruesome
Stock price: 4.499999999999999
P/E ratio: 15.775801437346434
Shares outstanding: 37221746
Book value: 506501086.95652175
P/B ratio: 0.33069594777469463
Market cap (USD): 167497856.99999997
Debt to equity: 0.39030346730875287
Current ratio: 1.5060731826786873
Quick ratio: 0.831645418801382
Effective tax rate (%): 47.96505433624547
Interest coverage ratio: 2.4947132329381607
COGS to revenue (%): 77.44236546641106
Free cash flow (dilution-adjusted): -21084782.608695652
Buyback yield (%): 0
Retained earnings: 312650000
Inventory turnover: 1.3143239914219955
Receivables turnover: 2.166800325794123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0977808921831402
FCF margin (%): -5.608903461975521
Rule of 40 score: -5.608903461975521
Financial ratios for 2HRA.DE — quarterly report dated 2025-06-30
Total revenue: 361511764.7058824
Gross profit: 88257647.05882353
Operating income: 3758823.529411765
Net income: -1430588.2352941176
Capital expenditures: 10496470.588235294
Operating cash flow: 38417647.05882353
Depreciation & amortization: 17234117.647058822
Net tangible assets: 447944705.88235295
Owner earnings: 5307058.823529409
Capex to operating income (%): 279.2488262910798
Buffett classification: The Gruesome
Stock price: 5.8
P/E ratio: 176.41220418148757
Shares outstanding: 37221746
Book value: 529332941.17647076
P/B ratio: 0.4078456298604457
Market cap (USD): 215886126.79999998
Debt to equity: 0.34952315122473776
Current ratio: 1.480852457400019
Quick ratio: 0.8093415358177893
Effective tax rate (%): 668.2242990654205
Interest coverage ratio: 1.0614617940199336
COGS to revenue (%): 75.58650763948778
Free cash flow (dilution-adjusted): 26801176.470588237
Buyback yield (%): 0
Retained earnings: 332208235.2941176
Inventory turnover: 1.217997325572249
Receivables turnover: 2.2595648305427485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.46440100990867494
FCF margin (%): 7.413638804367281
Revenue growth (%): -3.831847535034162
Rule of 40 score: 3.581791269333119
Financial ratios for 2HRA.DE — quarterly report dated 2025-09-30
Total revenue: 365357647.0588235
Gross profit: 89790588.23529412
Operating income: 6689411.764705882
Net income: -215294.11764705883
Capital expenditures: 22982352.94117647
Operating cash flow: 28608235.29411765
Depreciation & amortization: 17451764.70588235
Net tangible assets: 452278823.5294118
Owner earnings: -5745882.352941178
Return on net tangible assets (%): -1.2704292250745899
Capex to operating income (%): 343.56313753077734
Buffett classification: The Gruesome
Stock price: 5.8352941176470585
P/E ratio: 215.3765709051254
Shares outstanding: 37221746
Book value: 531878823.5294117
P/B ratio: 0.40836338254843546
Market cap (USD): 217199835.48235294
Debt to equity: 0.3559125585880907
Current ratio: 1.4202348894872956
Quick ratio: 0.7490001866318287
Effective tax rate (%): 107.11785297549592
Interest coverage ratio: 1.8593852190974491
COGS to revenue (%): 75.42391983358772
Free cash flow (dilution-adjusted): 4412941.176470588
Buyback yield (%): 0
Retained earnings: 331921176.47058827
Inventory turnover: 1.1629726723863998
Receivables turnover: 2.4733513857916534
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8317924351652468
FCF margin (%): 1.2078414704045028
Revenue growth (%): 1.063833249263707
Rule of 40 score: 2.27167471966821
Financial ratios for 2HRA.DE — annual report dated 2025-12-31
Total revenue: 1461395294.1176472
Gross profit: 364404705.88235295
Operating income: 30688235.29411765
Net income: -43203529.4117647
Capital expenditures: 63376470.5882353
Operating cash flow: 108396470.5882353
Depreciation & amortization: 67424705.88235295
Net tangible assets: 407681176.47058827
Owner earnings: -39155294.11764705
Return on net tangible assets (%): -9.604390974492754
Capex to operating income (%): 206.51715545332564
Buffett classification: The Gruesome
Stock price: 5.047058823529412
Shares outstanding: 37221746
Book value: 489507058.82352936
P/B ratio: 0.3837745302957838
Market cap (USD): 187860341.57647058
Debt to equity: 0.440039319267162
Current ratio: 1.309863918771591
Quick ratio: 0.7436589562727404
Interest coverage ratio: 2.3839334673734234
COGS to revenue (%): 75.0646038515971
SG&A to revenue (%): 3.758535356218795
Free cash flow (dilution-adjusted): 38442352.941176474
Buyback yield (%): 0
Retained earnings: 282250588.2352941
Inventory turnover: 5.407874819484639
Receivables turnover: 10.426359126734319
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.264589276810018
FCF margin (%): 2.6305239311987094
Revenue growth (%): 4.834669592370672
Rule of 40 score: 7.465193523569382
Financial ratios for 2HRA.DE — quarterly report dated 2025-12-31
Total revenue: 327651764.7058824
Gross profit: 94575294.11764707
Operating income: 11080000
Net income: -44430588.23529412
Capital expenditures: 19803529.411764707
Operating cash flow: 50864705.88235294
Depreciation & amortization: 15569411.764705883
Net tangible assets: 407681176.47058827
Owner earnings: -48664705.88235295
Return on net tangible assets (%): -11.936951885700765
Capex to operating income (%): 178.73221490762373
Buffett classification: The Gruesome
Stock price: 5.047058823529412
Shares outstanding: 37221746
Book value: 489507058.82352936
P/B ratio: 0.3837745302957838
Market cap (USD): 187860341.57647058
Debt to equity: 0.440039319267162
Current ratio: 1.309863918771591
Quick ratio: 0.7436589562727404
Interest coverage ratio: 5.37250427837992
COGS to revenue (%): 71.13542354867434
Free cash flow (dilution-adjusted): 30049411.76470588
Buyback yield (%): 0
Retained earnings: 282250588.2352941
Inventory turnover: 1.1490056430986584
Receivables turnover: 2.337639228128489
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5397317158902342
FCF margin (%): 9.171142963835347
Revenue growth (%): -10.320266362693761
Rule of 40 score: -1.1491233988584142
Financial ratios for 3369.HK — annual report dated 2021-12-31
Capital expenditures: 0
Operating cash flow: 393371011.6138148
Depreciation & amortization: 195015795.1098901
Buffett classification: The Gruesome
Stock price: 0.13205128205128205
Shares outstanding: 829853000
Market cap (USD): 109583152.56410256
Free cash flow (dilution-adjusted): 393371011.6138148
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3369.HK — annual report dated 2022-12-31
Total revenue: 994169688.7816092
Gross profit: 303577450.72988504
Operating income: 234384049.9152299
Net income: 194980559.49568963
Capital expenditures: 101422027.704023
Operating cash flow: 349755804.7801724
Depreciation & amortization: 177821867.21982756
Net tangible assets: 2064875696.099138
Owner earnings: 271380399.01149416
Return on net tangible assets (%): 13.142699075018061
Capex to operating income (%): 43.27172763705743
Buffett classification: The Good
Stock price: 0.12066752246469832
P/E ratio: 0.5135707158646807
Shares outstanding: 829853000
Book value: 2618545448.946839
P/B ratio: 0.03824119438529182
Market cap (USD): 100136305.5198973
Debt to equity: 0.3788988656422012
Current ratio: 1.702649449992291
Quick ratio: 1.6622143063032975
Effective tax rate (%): 18.405794506190063
Interest coverage ratio: 6.960752132985928
COGS to revenue (%): 69.46422183702562
R&D to revenue (%): 2.0809729684627363
SG&A to revenue (%): 1.539583087916943
Free cash flow (dilution-adjusted): 247752272.60344827
Buyback yield (%): 0
Retained earnings: 583406351.4094827
Inventory turnover: 38.36646738866065
Receivables turnover: 148.41277844963403
Capitalized R&D asset: 20688402.4841954
ROCI (R&D-adjusted, %): 6.9129854422316255
FCF margin (%): 24.920521657331722
Rule of 40 score: 24.920521657331722
Financial ratios for 3369.HK — annual report dated 2023-12-31
Total revenue: 992248077.9690576
Gross profit: 295940101.8776371
Operating income: 236393147.5428973
Net income: 220038364.8607595
Capital expenditures: 147542085.53586498
Operating cash flow: 336680605.8016878
Depreciation & amortization: 189049306.06610408
Net tangible assets: 2179369424.6244726
Owner earnings: 261545585.39099857
Return on net tangible assets (%): 12.000975256228784
Capex to operating income (%): 62.413858891189356
Buffett classification: The Good
Stock price: 0.15749039692701666
P/E ratio: 0.5939595053970647
Shares outstanding: 829853000
Book value: 2724628435.2700424
P/B ratio: 0.047967596854402744
Market cap (USD): 130693878.36107557
Debt to equity: 0.3163238293244124
Current ratio: 1.1127415231752162
Quick ratio: 1.0666314495633291
Effective tax rate (%): 16.92221075949899
Interest coverage ratio: 7.112600171596916
COGS to revenue (%): 70.17478708717985
R&D to revenue (%): 2.1835301536750906
SG&A to revenue (%): 1.5433942593028922
Free cash flow (dilution-adjusted): 187446181.65822783
Buyback yield (%): 0
Retained earnings: 713800271.8255978
Inventory turnover: 33.969781601761696
Receivables turnover: 104.02678403411673
Capitalized R&D asset: 35527265.646126814
ROCI (R&D-adjusted, %): 6.9050877207696875
Rosenberg metric: -0.36916087929371993
FCF margin (%): 18.891060191509204
Revenue growth (%): -0.1932880105112258
Rule of 40 score: 18.69777218099798
Financial ratios for 3369.HK — annual report dated 2024-12-31
Total revenue: 940462408.409589
Gross profit: 282494273.4493151
Operating income: 198517068.1219178
Net income: 215697290.46027395
Capital expenditures: 117382432.94520548
Operating cash flow: 330842051.0876712
Depreciation & amortization: 177547503.1890411
Net tangible assets: 2257329542.721918
Owner earnings: 275862360.70410955
Return on net tangible assets (%): 12.22073939507614
Capex to operating income (%): 59.12964263260019
Buffett classification: The Good
Stock price: 0.24871134020618557
P/E ratio: 0.9568680782391947
Shares outstanding: 829853000
Book value: 2776878875.4739723
P/B ratio: 0.07432583884988334
Market cap (USD): 206393851.80412373
Debt to equity: 0.2563320226292121
Current ratio: 1.672100897315536
Quick ratio: 1.6248920564392897
Effective tax rate (%): 17.138035066941303
Interest coverage ratio: 8.40891830606476
COGS to revenue (%): 69.96219403101506
R&D to revenue (%): 2.529674104804584
SG&A to revenue (%): 1.7411058103509995
Free cash flow (dilution-adjusted): 187149371.61232877
Buyback yield (%): 0
Retained earnings: 834621905.5863013
Inventory turnover: 34.192918783482455
Receivables turnover: 75.24501153983144
Capitalized R&D asset: 45134050.93849304
ROCI (R&D-adjusted, %): 5.793361907467037
Rosenberg metric: -0.6205947612968536
FCF margin (%): 19.899718472407212
Revenue growth (%): -5.219024426377715
Rule of 40 score: 14.680694046029497
Financial ratios for 3369.HK — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.28406169665809766
Shares outstanding: 829853000
Market cap (USD): 235729451.1568123
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3369.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 2383303628.543933
Buffett classification: The Gruesome
Stock price: 0.2853503184713376
Shares outstanding: 829853000
Book value: 2915996519.0739193
P/B ratio: 0.08120682459168332
Market cap (USD): 236798817.83439493
Debt to equity: 0.22970901877214828
Current ratio: 1.9211983654119724
Quick ratio: 1.8756672966352839
Buyback yield (%): 0
Retained earnings: 921288433.930265
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3369.HK — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.36118251928020567
Shares outstanding: 829853000
Market cap (USD): 299728397.1722365
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 352A.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.21339606974813
Shares outstanding: 12920871
Market cap (USD): 106124231.0891226
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3937.T — annual report dated 2022-03-31
Total revenue: 38734297.65612195
Gross profit: 16419226.356335027
Operating income: 8467751.188329782
Net income: 6819734.469759056
Capital expenditures: 260408.12981478448
Operating cash flow: 7163891.165382724
Depreciation & amortization: 934240.2884772988
Net tangible assets: 31060317.98065891
Owner earnings: 7493566.628421571
Return on net tangible assets (%): 24.125852906875497
Capex to operating income (%): 3.075292648816581
Buffett classification: The Great
Stock price: 18.68439600065563
P/E ratio: 33.21470017048732
Shares outstanding: 12123241
Book value: 31245066.38256024
P/B ratio: 7.249638483143577
Market cap (USD): 226515435.6553844
Debt to equity: 0.08602754658791566
Current ratio: 3.0793721134123393
Quick ratio: 3.0785732233914995
Effective tax rate (%): 19.939329974321552
Interest coverage ratio: 141.96688650728223
COGS to revenue (%): 57.61060469591921
Free cash flow (dilution-adjusted): 6719300.1147352895
Buyback yield (%): 0.09219081308690744
Retained earnings: 18605941.648910016
Inventory turnover: 2327.251282051282
Receivables turnover: 5.094777656688085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.839559240173713
FCF margin (%): 17.347158774862425
Rule of 40 score: 17.347158774862425
Financial ratios for 3937.T — annual report dated 2023-03-31
Total revenue: 39389421.921921924
Gross profit: 15395570.570570571
Operating income: 7594527.027027028
Net income: 4307755.255255256
Capital expenditures: 341043.54354354355
Operating cash flow: 6161088.588588589
Depreciation & amortization: 1178536.0360360362
Net tangible assets: 30556186.186186187
Owner earnings: 5145247.747747748
Return on net tangible assets (%): 16.838645099216627
Capex to operating income (%): 4.490648888730722
Buffett classification: The Great
Stock price: 14.362162162162162
P/E ratio: 40.419184205175036
Shares outstanding: 12123241
Book value: 30708761.261261266
P/B ratio: 5.669911322428305
Market cap (USD): 174115953.17297298
Debt to equity: 0.05988474985496553
Current ratio: 3.619864502396086
Quick ratio: 3.619864502396086
Effective tax rate (%): 38.014521044279356
Interest coverage ratio: 74.87720207253886
COGS to revenue (%): 60.91445413672785
Free cash flow (dilution-adjusted): 5779504.504504505
Buyback yield (%): 1.1642814243941264
Retained earnings: 20553160.66066066
Receivables turnover: 6.058406609585283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.67803627442013
FCF margin (%): 14.672732481224763
Revenue growth (%): 1.691328629774276
Rule of 40 score: 16.36406111099904
Financial ratios for 3937.T — annual report dated 2024-03-31
Total revenue: 39240900.68674062
Gross profit: 14847781.299524564
Operating income: 7080711.8330692025
Net income: 3474267.036450079
Capital expenditures: 775640.5176967776
Operating cash flow: 4799914.157422082
Depreciation & amortization: 1163193.3438985737
Net tangible assets: 31077430.00528262
Owner earnings: 3861819.8626518752
Return on net tangible assets (%): 12.426445372076884
Capex to operating income (%): 10.954273185843928
Buffett classification: The Great
Stock price: 7.9230718436344425
P/E ratio: 27.647071573070438
Shares outstanding: 12123241
Book value: 31166078.975171685
P/B ratio: 3.0819824815696286
Market cap (USD): 96053309.42069466
Debt to equity: 0.061149105966768445
Current ratio: 3.2794395923886905
Quick ratio: 3.2794395923886905
Effective tax rate (%): 42.72163749820374
Interest coverage ratio: 64.74086820020527
COGS to revenue (%): 62.16246915092648
Free cash flow (dilution-adjusted): 3877839.40834654
Buyback yield (%): 0
Retained earnings: 20698659.535129424
Receivables turnover: 4.61056280495516
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.78970006341781
FCF margin (%): 9.88213659850282
Revenue growth (%): -0.3770586820890695
Rule of 40 score: 9.50507791641375
Financial ratios for 3937.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 35882532.5675865
Buffett classification: The Gruesome
Stock price: 9.34318532007284
Shares outstanding: 12123241
Book value: 35953361.815380305
P/B ratio: 3.150461643184925
Market cap (USD): 113269687.34290516
Debt to equity: 0.04209765768285905
Current ratio: 3.5630845756051115
Quick ratio: 3.5630845756051115
Buyback yield (%): 0
Retained earnings: 23977805.01470794
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3937.T — annual report dated 2025-03-31
Total revenue: 42380624.24809517
Gross profit: 16782241.67891993
Operating income: 8792741.612083945
Net income: 5737187.54177249
Capital expenditures: 182509.0228579067
Operating cash flow: 6221300.628258254
Depreciation & amortization: 1316889.4532816468
Net tangible assets: 37296999.064296216
Owner earnings: 6871567.972196231
Return on net tangible assets (%): 18.423916520335457
Capex to operating income (%): 2.075678223127618
Buffett classification: The Great
Stock price: 8.20405026066034
P/E ratio: 17.335964313861403
Shares outstanding: 12123241
Book value: 37440108.27429488
P/B ratio: 2.6565008241277916
Market cap (USD): 99459678.48609813
Debt to equity: 0.07274086903308924
Current ratio: 3.727708026527238
Quick ratio: 3.727708026527238
Effective tax rate (%): 36.16838379369193
Interest coverage ratio: 76.57121238577498
COGS to revenue (%): 60.40114562570603
Free cash flow (dilution-adjusted): 5623071.781847347
Buyback yield (%): 0.0003763148231159864
Retained earnings: 25656763.8016308
Receivables turnover: 5.328812952542305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.57098953842178
FCF margin (%): 13.268024909048101
Revenue growth (%): 8.001150601559589
Rule of 40 score: 21.26917551060769
Financial ratios for 3937.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 37296999.064296216
Buffett classification: The Gruesome
Stock price: 8.20405026066034
Shares outstanding: 12123241
Book value: 37440108.27429488
P/B ratio: 2.6565008241277916
Market cap (USD): 99459678.48609813
Debt to equity: 0.07274086903308924
Current ratio: 3.727708026527238
Quick ratio: 3.727708026527238
Buyback yield (%): 0
Retained earnings: 25656763.8016308
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3937.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.3303349017437025
Shares outstanding: 12123241
Market cap (USD): 76744175.62455022
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3937.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 37033876.17765814
Buffett classification: The Gruesome
Stock price: 7.09872139973082
Shares outstanding: 12123241
Book value: 37447886.9448183
P/B ratio: 2.298113921557387
Market cap (USD): 86059510.32079408
Debt to equity: 0.06158257433030308
Current ratio: 3.7524605223625396
Quick ratio: 3.7524605223625396
Buyback yield (%): 0
Retained earnings: 26384845.22207268
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3SQ1.DE — annual report dated 2021-12-31
Total revenue: 941342.0454545454
Gross profit: 188578.4090909091
Operating income: -337232.95454545453
Net income: -271762.5
Capital expenditures: 0
Depreciation & amortization: 135639.77272727274
Net tangible assets: 1402706.8181818181
Owner earnings: -136122.72727272726
Return on net tangible assets (%): -9.70428927187856
Buffett classification: The Gruesome
Stock price: 2.272727272727273
Shares outstanding: 2658349
Book value: 2104826.1363636367
P/B ratio: 2.870404433102064
Market cap (USD): 6041702.272727273
Debt to equity: 0.08918896885782511
Current ratio: 4.190169184999068
Quick ratio: 3.850370329465524
Interest coverage ratio: -9.071221152376586
COGS to revenue (%): 79.96706829345435
SG&A to revenue (%): 29.39710109237175
Buyback yield (%): 0
Inventory turnover: 4.485560092361238
Receivables turnover: 3.4163140573577806
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.709927943584141
Rule of 40 score: 0